management of febrile infants and young children
TRANSCRIPT
-
8/13/2019 Management of Febrile Infants and Young Children
1/48
Management of the Febrile Infant
and Young Child
Benjamin P. Harrison, MD, LTC, MC, USA
Program Director, Madigan-University of WashingtonEmergency Medicine Residency
*Revised from previous edition by Ann Egland, MD and Kim Forman, MD
Government Services Chapter
American College of Emergency Physicians
-
8/13/2019 Management of Febrile Infants and Young Children
2/48
GSACEP 2005
Scope of the Problem
Fever = Temp > 100.4 F or 38.0 C (some
use 100.5 or greater)
10-20% of all pediatric visits to the ER.
20% will have fever without source
-
8/13/2019 Management of Febrile Infants and Young Children
3/48
GSACEP 2005
Approach to the
Febrile Infant / Child
The Great Debate
Approaches in the 1 month36 month old
febrile infant/child vary greatly
Guidelines change as disease prevalence
fluctuates; data/studies conflict at times
Grey Areas are abundant; be open to change!One-size-fits-all approach discouraged
-
8/13/2019 Management of Febrile Infants and Young Children
4/48
GSACEP 2005
Occult Bacteremia
Transient bacteremia is a daily occurrence
(tooth brushing, dental or bowel
procedures)
Identifying occult bacteremia increases with
increasing fever, WBC, and ANC.
Vast majority of infants/children with fever
are viral, even if hyperpyrexic
-
8/13/2019 Management of Febrile Infants and Young Children
5/48
GSACEP 2005
Occult Bacteremia
2-3% of febrile children < 3 y.o. had occult
bacteremia in past (H. influenza B and S
pneumoniae predominately)
Numbers much lower now
OPB = occur pneumococcal bacteremia
SBI = serious bacterial infection
-
8/13/2019 Management of Febrile Infants and Young Children
6/48
GSACEP 2005
Occult Bacteremia
By definition, a well-appearing child with
bacteria in his/her blood.
Initially bacteremia occult or hidden
May progress to toxicity, septic shock or
produce focal infections
-
8/13/2019 Management of Febrile Infants and Young Children
7/48
GSACEP 2005
Incidence of Occult Bacteremia (Post HiBand Pre Pneumococcal Vaccine Era)
1.9% incidence of bacteremia
82.9% S. pneumoniae13 times more likely to be pathogen (vs.
contaminant) if grew in less than 18 hrs.
95.7% resolved without parenteralantibiotics
-
8/13/2019 Management of Febrile Infants and Young Children
8/48
GSACEP 2005
Predictors of Occult Bacteremia
Age Dependent
Premature InfantsInfants and children
Birth to 28 days
28-60 days 2 to 36 months
Above 3 years
-
8/13/2019 Management of Febrile Infants and Young Children
9/48
GSACEP 2005
Predictors of Occult Bacteremia
OPB pts younger, ill-appearing, with
higher temperatures, WBC, ANC, and ABC
Occult bacteremia in 8.1% with ANC
>10,000 vs. 0.8% if ANC
-
8/13/2019 Management of Febrile Infants and Young Children
10/48
GSACEP 2005
Predictors of Occult Bacteremia
When a recognizable viral syndrome
present, low risk for occult bacteremia.
i.e. Croup, varicella, bronchiolitis,
stomatitis
0.2% rate of occult bacteremiaBlood cultures are not indicated in these
cases
-
8/13/2019 Management of Febrile Infants and Young Children
11/48
GSACEP 2005
Occult Urinary Tract Infections
Occult UTIs 4% of boys < 12 mos and 9% of
girls < 24 mos (Not immunized against E. coli !)
Uncircumcised males more at risk
UA & urine culture < 6 months for circumcised
and < 12 months old in uncircumcised
Get UA in hyperpyrexia even if other sourcespresent (AOM, AGE, etc)
-
8/13/2019 Management of Febrile Infants and Young Children
12/48
GSACEP 2005
Occult UTI Diagnosis
Urine Culture > 103-105 cfus = gold std
Tr. LE, > 10 WBC/hpf and neg- Gm stain or
no bacteria are all highly senstitive
Nit +, >Mod LE, + Gm Stain, > 10
WBC/hpf and bacteruria are all very
specific for UTI on cath UA
-
8/13/2019 Management of Febrile Infants and Young Children
13/48
GSACEP 2005
Occult Urinary Tract Infection
75% of febrile UTIs are pyelonephritis
Consequences of missed pyelonephritis in
childhood
Renal scarring in 27-64% (with risk of HTN,
renal failure and pre-eclampsia as an adult)
13-15% of end-stage renal disease is thought tobe related to under-treated childhood UTI.
-
8/13/2019 Management of Febrile Infants and Young Children
14/48
GSACEP 2005
Occult Pneumonia
40% of children suspected of pneumonia
confirmed with CXR
26% without pneumonia clinically had
positive CXR in subgroup with WBC >
20,000
Strongly consider CXR in children < 5 y.o.
with WBC > 15K even if normal RR, pulse Ox
and lung exam!
-
8/13/2019 Management of Febrile Infants and Young Children
15/48
GSACEP 2005
Consequences of Missing OPB
10-25% of children with OPB will
develop cellulitis, pneumonia, or sepsis
if not treated
3-6% will develop meningitis (Pre
Prevnar) Much lower numbers now
-
8/13/2019 Management of Febrile Infants and Young Children
16/48
GSACEP 2005
Why Not Treat All Highly Febrile
Children with Antibiotics?
Indiscriminate use of antibioticscontributes to emerging resistance of S.
pneumoniae
Adverse drug reactions
Decreases patient discomfort and EDcosts
-
8/13/2019 Management of Febrile Infants and Young Children
17/48
GSACEP 2005
The Febrile Child
Rectal temperature is the gold standard
Age > 36 months much less at risk
Definition of fever for selective protocols to
be discussed are as follows:
Birth to 28 days
29-90 days
3-36 months
-
8/13/2019 Management of Febrile Infants and Young Children
18/48
GSACEP 2005
What about the Temperature?
Recent immunization history
Overbundling is not the cause of a fever
Accept the T-max at home
Parents good at identifying fever (tactile)
Normal/low temp doesnt preclude SBI
-
8/13/2019 Management of Febrile Infants and Young Children
19/48
GSACEP 2005
Toxic Appearing?
Eval toxic-appearing children immediately
Septic workup and admit, regardless of age
Toxicity is defined as:
Lethargy
Signs of poor perfusion
Hypoventilation, hyperventilation, or cyanosis
I.E. Shock / sepsis / meningitis / encephalitis
-
8/13/2019 Management of Febrile Infants and Young Children
20/48
GSACEP 2005
Approach to the Toxic Patient
Fever alone may make a child appear ill
Ask about childs behavior when not febrile
and observe in ED if afebrile
Normal?
Still ill appearing?
Eating/drinking?
-
8/13/2019 Management of Febrile Infants and Young Children
21/48
GSACEP 2005
Vital Signs
Fifth Vital Sign
Pulse Ox mandatory with abnormal lung
exam, resp rate or respiratory symptoms
RR will increase with fever
Pulse oximetry more reliable predictor infection
than respiratory rate
-
8/13/2019 Management of Febrile Infants and Young Children
22/48
GSACEP 2005
Vital signs
Address Abnormal Vital Signs
Get accurate weight for treatment
Elevated pulse may be from fever or crying
Repeat pulse after antipyretics or hydration
Try to document vitals when patient is calm
-
8/13/2019 Management of Febrile Infants and Young Children
23/48
GSACEP 2005
Physical Exam Findings
Petechial / purpuric rashes (invasive
bacteremia)
Toxic appearance and WBC >15,000 are
100% sensitivity for identification these
rashes
Meningococcemia associated with purpura
more than petechiae alone.
-
8/13/2019 Management of Febrile Infants and Young Children
24/48
GSACEP 2005
Birth to 28 Days Old
Documented temperature above 100.4
degrees F requires a full septic work-
up and admission
-
8/13/2019 Management of Febrile Infants and Young Children
25/48
GSACEP 2005
Birth to 28 Days Old
Septic work-up includes:
CBC with manual differential
Blood culture
Urinalysis and urine culture
CXR
LP for CSF analysis and culture; Herpes PCRTesting
Stool culture and fecal WBCs for diarrhea
-
8/13/2019 Management of Febrile Infants and Young Children
26/48
GSACEP 2005
Birth to 28 Days Old
If ill-appearing, give parenteral antibiotics
once urine/blood obtained ( < 30 mins &
before LP !)
Ampicillin 50-100 mg/kg/dose IV +
Cefotaxime 50 mg/kg/dose IV up to 2g
OR Ampicillin + Gentamicin 2.5 mg/kg IV
-
8/13/2019 Management of Febrile Infants and Young Children
27/48
GSACEP 2005
Nontoxic 28 to 90 Days Old
Various approaches and debatable area
10% will have aseptic meningitis if LP done
Management also depends on risk factors
Low Risk Group may be discharged home
High Risk Group requires more extensive
workup and admission
-
8/13/2019 Management of Febrile Infants and Young Children
28/48
GSACEP 2005
28 to 90 Days Old
Low Risk Patients
No bacterial focus on PE (excluding OM)
Non-toxic, previously healthy
Not hospitalized, term infant , no antibiotics
Reliable parents with car/phone, close F/U
-
8/13/2019 Management of Febrile Infants and Young Children
29/48
GSACEP 2005
28 to 90 Days Old
Low Risk Patients
WBC 5-15k (
-
8/13/2019 Management of Febrile Infants and Young Children
30/48
GSACEP 2005
Nontoxic 28 to 90 Days Old
Most conservative approach
Full Septic Workup
Antibiotics within 30 minutes of arrival
Ceftriaxone 100 mg/kg o.k. after 6 weeks age
Admit pending culture results
Consider Acyclovir treatment if Herpes
PCR testing not returned yet and CSF
results not clearly bacterial in etiology
-
8/13/2019 Management of Febrile Infants and Young Children
31/48
GSACEP 2005
Nontoxic 28 to 90 Days Old
The Minimalist approach
UA, Blood and Urine cultures
1 in 1,000 missed meningitis (most viral) if
no LPparents/provider o.k. with that risk?
No antibiotics
Follow up visit in 24 hours
-
8/13/2019 Management of Febrile Infants and Young Children
32/48
GSACEP 2005
Nontoxic 28 to 90 Days Old
My Approach
Lab/CXR work-up for fever >38 degrees C /100.4 degrees F, observe patient in ED
No antibiotics if no LP and Close F/Uensured
LP added if:
Younger patient (2860 days) with high feverIll, but non-toxic, appearing or any other
concern while observing
-
8/13/2019 Management of Febrile Infants and Young Children
33/48
GSACEP 2005
-
8/13/2019 Management of Febrile Infants and Young Children
34/48
GSACEP 2005
Toxic 3 to 36 Months Old
Toxic appearing? Concern for sepsis or
meningitis?
Treat empirically
Ceftriaxone 100 mg/kg IV up to 4G OR
Vancomycin 15 mg/kg IV up to 500 mg AND
Cefotaxime 50 mg/kg IV up to 2G
-
8/13/2019 Management of Febrile Infants and Young Children
35/48
GSACEP 2005
3 to 36 Months Old
Well appearing with clear source of fever:
Treat and send home with follow-up
Patient has a source but appears toxic:
LP, antibiotics and admit
Well appearing but no clear source of fever;
Debatable approachdepends on
immunization status
-
8/13/2019 Management of Febrile Infants and Young Children
36/48
GSACEP 2005
Why Treat in
Pre-HiB and Pre-Prevnar Era?
Patients who received oral antibiotics later
identified with OPB had fewer serious
bacterial infections (3.3% vs. 9.7%).
Meningitis developed in 0.8% vs. 2.7%,
respectively.
h ld
-
8/13/2019 Management of Febrile Infants and Young Children
37/48
GSACEP 2005
Nontoxic 3 to 36 Months Old
Not Immunized
< 24 months old with 39 C (102.2 F) fever
without a identifiable source needs further
work-up
24-36 months old, 39.5 C (103 F) used
because risk of bacteremia increases to2.1% from 0.7% with fever 39 C to 39.4 C.
d
-
8/13/2019 Management of Febrile Infants and Young Children
38/48
GSACEP 2005
Nontoxic Un-immunized
3 to 36 Months Old
Labs recommended in those without a
source:
Blood culture
CBC
Cath U/A and urine culture (as indicated)
CXR for tachypnea, retractions, focalabnormalities, room air SaO2 < 95%
-
8/13/2019 Management of Febrile Infants and Young Children
39/48
GSACEP 2005
N i U i i d
-
8/13/2019 Management of Febrile Infants and Young Children
40/48
GSACEP 2005
Nontoxic Un-immunized
3 to 36 Months Old
If urine or CXR is positive, treat with appropriate
antibiotics for UTI or pneumonia
If ANC > 10k (or WBC > 15k), send blood culturethen give ceftriaxone 50 mg/kg IV/IM
Follow-up with ED or PCM in 24 hours to check
culture results, reassess the patient and consider
need for further antibiotic treatment.
-
8/13/2019 Management of Febrile Infants and Young Children
41/48
N i I i d*
-
8/13/2019 Management of Febrile Infants and Young Children
42/48
GSACEP 2005
Nontoxic Immunized*
3 to 36 Months Old
> 95% infants with serotype specific
antibodies after 2 doses Prevnar
Herd immunity / lower invasive disease
After 2 doses HiB and Prevnar vaccines,
UTI alone is primary concern if no source
* At least 2 doses each of HiB and
Pneumococcal vaccines
-
8/13/2019 Management of Febrile Infants and Young Children
43/48
GSACEP 2005
3 to 36 Months Old
Advise parents/caretakers to return
immediately if the child is worse
Follow-up in the appropriate clinic/PCM
office if not improving or for culture results
-
8/13/2019 Management of Febrile Infants and Young Children
44/48
GSACEP 2005
3 Years Old and Up
After a careful history and physical to
identify possible fever causes, treatment
should be tailored to specific causes only.
In the well-appearing child without a
source, no further evaluation is indicated.
Occult serious bacterial infection in childrenover 3 years is extremely low.
-
8/13/2019 Management of Febrile Infants and Young Children
45/48
GSACEP 2005
3 Years Old and Up
Treat fever with anti-pyretics:
Acetaminophen 15- 20 mg/kg every 4 hours
and/or Ibuprofen 10 mg/kg every 6-8 hours
Advise parents to return immediately if the
child is worse and to follow-up with his/her
PCM if not improving.
-
8/13/2019 Management of Febrile Infants and Young Children
46/48
GSACEP 2005
Special Cases
Any child with a complicated or significant
medical history should be treated
conservatively.
Clinical judgment must be used.
Febrile children with sickle cell disease
under age 4 are usually admitted.
-
8/13/2019 Management of Febrile Infants and Young Children
47/48
GSACEP 2005
Summary
Treatment of the febrile infant and young
child depends on:
Appearance
Fever
Age
Past Medical History
Immunization Status
-
8/13/2019 Management of Febrile Infants and Young Children
48/48
Summary
Bloodwork rarely helpful
Do complete History and PE
Ensure appropriate admission
Arrange close F/U or return to ED
Always tell the parents to return if the childis getting worse!